Detalhe da pesquisa
1.
Adding immunotherapy to first-line treatment of advanced and metastatic endometrial cancer.
Ann Oncol
; 35(5): 414-428, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38431043
2.
Inclusion, diversity, equity, and access (IDEA) in gynecologic cancer clinical trials: A joint statement from GOG foundation and Society of Gynecologic Oncology (SGO).
Gynecol Oncol
; 174: 278-287, 2023 07.
Artigo
Inglês
| MEDLINE | ID: mdl-37315373
3.
Independent psychometric validation of European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Endometrial Cancer Module (EORTC QLQ-EN24).
Eur J Cancer Care (Engl)
; 27(1)2018 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-28058740
4.
Immunotherapy toxicities: An SGO clinical practice statement.
Gynecol Oncol
; 166(1): 25-35, 2022 07.
Artigo
Inglês
| MEDLINE | ID: mdl-35597686
5.
Early initiation of chemotherapy following complete resection of advanced ovarian cancer associated with improved survival: NRG Oncology/Gynecologic Oncology Group study.
Ann Oncol
; 27(1): 114-21, 2016 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-26487588
6.
Epidemiology, diagnosis, and treatment of gestational trophoblastic disease: A Society of Gynecologic Oncology evidenced-based review and recommendation.
Gynecol Oncol
; 163(3): 605-613, 2021 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34686354
7.
Viewing the immune checkpoint VISTA: landscape and outcomes across cancers.
ESMO Open
; 9(4): 102942, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38503143
8.
New paradigms in the surgical and adjuvant treatment of ovarian cancer.
Minerva Ginecol
; 66(2): 179-92, 2014 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-24848076
9.
A retrospective review of the effect of surgeon specialty on the management of 190 benign and malignant pediatric and adolescent adnexal masses.
J Pediatr Adolesc Gynecol
; 24(5): 282-5, 2011 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-21600810